• Home
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Founder’s Vision
  • Journal PharmaceuticalIntelligence.com
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder’s Bio
  • Funding, Deals & Partnerships
  • 1.0 LPBI Group News
  • 1.0 LPBI CALENDAR
  • 2.0 LPBI Group News
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2025 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • Blockchain Transactions Network Ecosystem
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • SOP Web STAT
  • Synthetic Biology in Drug Discovery
  • Certificate One Year
  • NFT: Redefined Format of IP Assets
  • Audio English-Spanish: BioMed e-Series
  • Five Bilingual BioMed e-Series
  • Press Releases
  • Intangibles CIM
  • Composition of Methods (COM)
  • BioMed Audio Podcast Library @LPBI Group
  • Medical School Education: Use of LPBI Group’s Contents
  • ChatGPT + Wolfram PlugIn
  • Medicine with GPT-4 & ChatGPT
  • AGI, generativeAI, Grok, DeepSeek & Expert Models in Healthcare
  • Multimodal Healthcare Foundation Model
  • Grok 4 aids Exit
  • Contact Us

Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

Healthcare analytics, AI solutions for biological big data, providing an AI platform for the biotech, life sciences, medical and pharmaceutical industries, as well as for related technological approaches, i.e., curation and text analysis with machine learning and other activities related to AI applications to these industries.

Feeds:
Posts
Comments

Part Two: List of BioTech Conferences 2013 to Present

Part Two:

List of BioTech Conferences 2013 to Present

Total Number of Conferences Covered

by Aviva Lev-Ari, PhD, RN, per year,

2013 – Present, N = 

 

Total Views of Total # Conferences Covered

by Aviva Lev-Ari, PhD, RN, per year,

2013 – Present, N =

@@@@@@@

 

Total Number of Conferences Covered

by Stephen J. Williams, PhD, per year,

2015 – Present, N = 

 

Total Views of Total # Conferences Covered

by Stephen J. Williams, PhD, per year,

2015 – Present, N =

LPBI Group

Total # Conferences Covered per year, 2013 – Present,

N =

Total Views of Total # Conferences Covered, 2013 – Present,

N =

e-Proceedings (N = )

Total Views: All Years

N =

Tweet Collections (N = )

Total Views: All Years

N =

To See all Conferences covered by Aviva

  • List of Medical, Pharmaceutical and BioTech Conferences Covered by Aviva Lev-Ari, PhD, RN, 2013 to Present: Total # and Total Views

and

To See all Conferences covered by Dr. Williams

  • List of Medical, Pharmaceutical and BioTech Conferences Covered by Stephen J. Williams, PhD, 2015 to Present: Total # and Total Views

To See all e-Proceedings and all Tweet Collections

https://pharmaceuticalintelligence.com/press-coverage/part-three-conference-eproceedings-deliverables-social-media-analytics/

YEAR

# Conference Events

per Year

Total Views for Event Announcement per Year e-Proceedings Views

per Year

Tweet Collections Views

per Year

2026

       

2025

Real Time

       

2024

Real Time

       

2023

Virtual

       

2022

Virtual

       

2021

Virtual

       

2020

Virtual

       

2019

Real Time

       

2018

Real Time

       

2017

Real Time

       

2016

Real Time

       

2015

Real Time

       

2014

Real Time

       

2013

Real Time

       

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to print (Opens in new window) Print
  • Click to email a link to a friend (Opens in new window) Email

Like this:

Like Loading...

This page has the following sub pages.

  • List of Medical, Pharmaceutical and BioTech Conferences Covered by Aviva Lev-Ari, PhD, RN, 2013 to Present: Total # and Total Views
  • List of Medical, Pharmaceutical and BioTech Conferences Covered by Stephen J. Williams, PhD, 2015 to Present: Total # and Total Views

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 9,314 other subscribers
  • Recent Posts

    • 2025 Grok 4.1 Causal Reasoning & Multimodal on Identical Proprietary Oncology Corpus: From 673 to 5,312 Novel Biomedical Relationships: A Direct Head-to-Head Comparison with 2021 Static NLP – NEW Foundation Multimodal Model in Healthcare: LPBI Group’s Domain-aware Corpus Transforms Grok into the “Health Go-to Oracle” December 15, 2025
    • Marquee Followers 80% Healthcare Persons and Institutions for @AVIVA1950 and @Pharma_BI December 8, 2025
    • Exploratory Protocol for Comparison of NLP to LLM on Same Oncology Slice December 8, 2025
    • Valuation Models per Ten Digital IP Asset Classes in LPBI Group’s Portfolio of IP December 8, 2025
    • Protected: How will gold and silver medal for Grok be achieved for Domain-aware “AI in Health”: Pharmaceutical/BioPharma, Medical/Diagnosis and Therapeutics, Life Sciences/Genomics and BioMed/Biotech/Medtech December 5, 2025
    • Generative AI Providers: Open Source and Closed source, Google’s JAX AI stack versus @xAI and @Grok December 3, 2025
    • In Memoriam to Michael R. Bristow, MD, PhD, A Visionary Leader in Heart Failure (HF) Cardiology December 1, 2025
    • AI and Health Day @AIW25, AI Week, December 9 – December 11, 2025, Tel Aviv University December 1, 2025
    • AI Initiatives in Big Pharma @Grok prompt & Proprietary Training Data and Inference by LPBI Group’s IP Asset Class X: +300 Audio Podcasts Library: Interviews with Scientific Leaders November 22, 2025
    • AI Initiatives in Big Pharma @Grok prompt & Proprietary Training Data and Inference by LPBI Group’s IP Asset Class V: 7,500 Biological Images in LPBI Group’s Digital Art Media Gallery, as Prior Art November 22, 2025
  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • 1 2012pharmaceutical
    • 1 sjwilliamspa

Powered by WordPress.com.

WPThemes.


%d